Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810679 · ClinicalTrials.gov registry record · NA
Perceval S Aortic Heart Valve Study- North America
A NA study, sponsored by Sorin Group USA.
- Terminated
- Registry status
- NA
- Development phase
- 355
- Enrollment target
NCT01810679: Clinical Trial NA study, sponsored by Sorin Group USA.
NCT01810679 is a NA study that was terminated before completion, run by Sorin Group USA. The registered enrollment target is 355 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01810679, a NA study, was terminated before completion, sponsored by Sorin Group USA.
- TERMINATED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
Study Summary
To demonstrate the safety and effectiveness of the Perceval S heart valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
Primary Outcome
To demonstrate that the complication and survival rates for the PERCEVAL S valve are comparable to appropriate historical controls manifested as objective performance criteria (OPCs) and to that reported for other stented bioprostheses in the literature
Interventions
- DEVICE Perceval S Aortic Heart Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-04 |
| Phase | NA |
Why NCT01810679 stopped before completion
NCT01810679 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which Perceval S Aortic Heart Valve is the first listed.
NCT01810679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01810679 about?
NCT01810679 is a clinical study titled "Perceval S Aortic Heart Valve Study- North America". To demonstrate the safety and effectiveness of the Perceval S heart valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
What is the current status of trial NCT01810679?
This trial is currently terminated. It is a NA study. The enrollment target is 355 participants. The study started on 2013-04. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01810679?
The interventions under investigation include: Perceval S Aortic Heart Valve (DEVICE).
Who is sponsoring clinical trial NCT01810679?
This trial is sponsored by Sorin Group USA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01810679's enrollment target sits among peer trials
355 291st of 2000 higher than 1,710 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia